Pharmaceuticals, Biotechnology and Life Sciences
Emergency Use Authorization (EUA) granted for individuals 65 years of age and older, and individuals ages 18 through 64 within…
10-target partnership leverages AbCellera’s technology to accelerate Everest’s pipeline of novel, innovative medicines to patients VANCOUVER, British Columbia & SHANGHAI–(BUSINESS…
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by…
Dr. Shin to help advance REN-001 into the clinic by leveraging nearly two decades of expertise in clinical development, academic…
AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid…
ICON secures Enterprise Ireland funding to enhance digital health technology and data analytics solutions DUBLIN, Ireland–(BUSINESS WIRE)–#CRO–The Tánaiste and Minister…
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused…
Boston Labs is launching in Q4 2021 a decentralized cell and gene therapy clinical contract manufacturing solution to biotech companies…
– Jakafi is approved for treatment of chronic GVHD after failure of one or two lines of systemic therapy in…
DUBLIN–(BUSINESS WIRE)–The “Global Obstructive Lung Disease Management Research Report” report has been added to ResearchAndMarkets.com’s offering. The report provides a…